Expression of Survivin According to Malignant Progression of Breast Lesions.
- Author:
Hyun Joo CHOI
1
;
Ji Han JUNG
;
Chan Kwon JUNG
;
Jinyoung YOO
;
Eun Jung LEE
;
Chang Suk KANG
;
Seok Jin KANG
;
Kyo Young LEE
Author Information
1. Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea. ejlpath@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Breast;
Survivin;
Immunohistochemistry
- MeSH:
Breast*;
Carcinoma, Ductal;
Cytoplasm;
Humans;
Hyperplasia;
Immunohistochemistry;
Lymph Nodes;
Neoplasm Metastasis;
Prognosis
- From:Korean Journal of Pathology
2007;41(4):238-243
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The aim of this study was to examine the survivin expression pattern in benign lesions, atypical ductal hyperplasias (ADH), ductal carcinomas in situ (DCIS) and in invasive carcinomas of the breast and to evaluate the effect of expression of this marker on the malignant progression of breast cancers. In addition, the relationship between the expression of the marker and the clinicopathological characteristics for invasive carcinomas were investigated. METHODS: Immunohistochemical staining using a tissue microarray method for survivin was performed for 103 benign lesions, 30 ADHs, 26 DCISs and 116 invasive carcinomas. RESULTS: The expression of cytoplasmic survivin was higher for invasive carcinomas than for ADHs and DCISs (p<0.05). For breast invasive carcinomas, expression of cytoplasmic survivin significantly correlated with tumor size, lymph node metastasis and stage (p<0.05). CONCLUSIONS: These results suggest that overexpression of cytoplasmic survivin may be involved in the development of the late stage of breast malignancy, especially invasiveness. In breast invasive carcinomas, expression of survivin may be a useful indicator for the evaluation of patient prognosis.
